Evidence map›Paper›PMID 11331772›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2001

Phenotypic consequences of lung-specific inducible expression of FGF-3.

B Zhao, S S Chua, M M Burcin, S D Reynolds, B R Stripp, R A Edwards, M J Finegold, S Y Tsai, F J DeMayo

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Inducible expression of FGF-3 in mouse mammary gland.Proceedings of the National Academy of Sciences of the United States of America · 2002
    Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

B ZhaoDepartment of Molecular and Cellular Biology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA.
S S Chua
M M Burcin
S D Reynolds
B R Stripp
R A Edwards
M J Finegold
S Y Tsai
F J DeMayo
University of Rochester · USBaylor College of Medicine · US

Funding

REGULATABLE GENE TRANSFER SYSTEMP01HL059314 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI CHAN, LAWRENCE · 1998 to 2007
$7.6M
STEM CELLS IN AIRWAY REPAIRR01HL064888 · NHLBI · UNIVERSITY OF ROCHESTER · PI STRIPP, BARRY R · 2000 to 2009
$3.1M
CLARA CELL SECRETION AND OXIDANT LUNG POLLUTANTSR01ES008964 · NIEHS · UNIVERSITY OF ROCHESTER · PI STRIPP, BARRY R · 1997 to 2008
$2.3M
NHLBI NIH HHS P01 HL059314NHLBI NIH HHS R01 HL064888NIEHS NIH HHS R01 ES008964
6 · The paper itself

Abstract

Members of the fibroblast growth factor (FGF) family play a critical role in embryonic lung development and adult lung physiology. The in vivo investigation of the role FGFs play in the adult lung has been hampered because the constitutive pulmonary expression of these factors often has deleterious effects and frequently results in neonatal lethality. To circumvent these shortcomings, we expressed FGF-3 in the lungs under the control of the progesterone antagonist-responsive binary transgenic system. Four binary transgenic lines were obtained that showed ligand-dependent induction of FGF-3 with induced levels of FGF-3 expression dependent on the levels of expression of the GLp65 regulator as well as the dose of the progesterone antagonist, RU486, administered. FGF-3 expression in the adult mouse lung resulted in two phenotypes depending on the levels of induction of FGF-3. Low levels of FGF-3 expression resulted in massive free alveolar macrophage infiltration. High levels of FGF-3 expression resulted in diffuse alveolar type II cell hyperplasia. Both phenotypes were reversible after the withdrawal of RU486. This system will be a valuable means of investigating the diverse roles of FGFs in the adult lung.

Indexed as

AnimalsFibroblast Growth Factor 3Fibroblast Growth FactorsLigandsLungMiceMice, TransgenicMifepristonePhenotypeProto-Oncogene ProteinsFgf3 protein, mouseFibroblast Growth Factor 3Fibroblast Growth FactorsLigandsMifepristoneProto-Oncogene Proteins

Identifiers

PMID11331772
PMCPMC33310
OpenAlexW2060716993

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.